Fortrea Beats Revenue Estimates, Misses Earnings

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded12 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2196887

Show notes

Fortreas Q3 earnings show robust revenue growth, surpassing analyst estimates by nearly 10%, driven by clinical pharmacology and development businesses. The company attributes this success to operational improvements and new technology, doubling win rates with biotech clients and securing high volumes of new business. However, adjusted earnings per share missed expectations due to higher pass-through costs. Fortrea raised its full-year revenue and EBITDA guidance, with investors reacting positively to the companys focus on operations and technology.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.